PharmatrophiX (PTX) is a privately held biopharmaceutical company focused on the
development of disease-modifying small molecule drugs targeting mechanisms underlying
neurodegenerative and other disorders.
PTX is operated as a virtual biotech company in Menlo Park, CA executing drug development
through contracted work. This virtual model is recognized as an effective way of minimizing
overhead costs while efficiently achieving drug development milestones.
Seed funding and additional corporatefunding has been provided by the peer-reviewed biotech support program of the
Alzheimer'sDrug Development Foundation (ADDF).
Developing small molecule drugs for
neurodegenerative and other diseases